Evidence map›Paper›PMID 31122100›Full record

ReviewCritical reviews in microbiology2019

The rise and spread of

Sue C Nang, Jian Li, Tony Velkov

Open access · greenAbstract readReview
In one paragraph

Review in Critical reviews in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 155 papers.

0numbers the graph read from it
0cells of the map it votes in
155citing papers in PubMed
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

155 citing papers in PubMed, 246 citations in OpenAlex.

  1. Public health challenges · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Adaptive colistin resistance dynamics inMicrobiology spectrum · 2026
    Article
  6. Antibiotic resistance mechanisms and global resistance patterns of Pseudomonas aeruginosa in microbial keratitis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  7. Review
  8. Species identification and genotyping ofMicrobiology spectrum · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Antibiotic resistance inFrontiers in microbiology · 2026
    Review
  19. Molecular epidemiology ofFrontiers in microbiology · 2026
    Article
  20. Article

95 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Sue C Nanga Department of Microbiology, Monash Biomedicine Discovery Institute , Monash University , Melbourne , Australia.
Jian Lia Department of Microbiology, Monash Biomedicine Discovery Institute , Monash University , Melbourne , Australia.
Tony Velkovb Department of Pharmacology and Therapeutics, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences , The University of Melbourne , Parkville , Australia.
Australian Regenerative Medicine Institute · AUMonash University · AUUniversity of Melbourne · AU

Funding

New Tricks for 'Old' Drugs: PK/PD of Polymyxin Nonantibiotic CombinationsR01AI111965 · NIAID · MONASH UNIVERSITY · PI LI, JIAN · 2014 to 2018
$4.3M
Targeting the Urgent Need for New Antibiotics against Gram-negative ‘Superbugs’R01AI132154 · NIAID · MONASH UNIVERSITY · PI LI, JIAN, VELKOV, TONY · 2017 to 2021
$4.3M
NIAID NIH HHS R01 AI111965NIAID NIH HHS R01 AI132154
6 · The paper itself

Abstract

Polymyxins are important lipopeptide antibiotics that serve as the last-line defense against multidrug-resistant (MDR) Gram-negative bacterial infections. Worryingly, the clinical utility of polymyxins is currently facing a serious threat with the global dissemination of

Indexed as

Drug Resistance, BacterialAnimalsAnti-Bacterial AgentsBacterial ProteinsGram-Negative BacteriaGram-Negative Bacterial InfectionsHumansPlasmidsPolymyxinsTransferases (Other Substituted Phosphate Groups)Anti-Bacterial AgentsBacterial ProteinsPolymyxinsTransferases (Other Substituted Phosphate Groups)Gram-negative bacteriapolymyxin resistance

Identifiers

PMID31122100
PMCPMC6625916
OpenAlexW2946148649

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.